Ownership history in Cornerstone Capital, Inc. · 87 quarters on record
This page tracks every 13F SEC filing in which Cornerstone Capital, Inc. reported a position in Abbott Laboratories COMMON (ABT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 219,639 | +210 | +0.1% | 2.71% | $27.5M | $124.66 |
| 2025 Q3 | ADDED | 219,429 | +3,987 | +1.9% | 2.88% | $29.4M | $132.67 |
| 2025 Q2 | REDUCED | 215,442 | -11,890 | -5.2% | 3.06% | $29.3M | $134.12 |
| 2025 Q1 | REDUCED | 227,332 | -2,117 | -0.9% | 3.25% | $30.2M | $130.21 |
| 2024 Q4 | REDUCED | 229,449 | -21,404 | -8.5% | 2.73% | $26.0M | $110.45 |
| 2024 Q3 | ADDED | 250,853 | +10,695 | +4.5% | 2.67% | $28.6M | $110.80 |
| 2024 Q2 | REDUCED | 240,158 | -1,685 | -0.7% | 2.52% | $25.0M | $100.45 |
| 2024 Q1 | ADDED | 241,843 | +203 | +0.1% | 2.82% | $27.5M | $109.34 |
| 2023 Q4 | REDUCED | 241,640 | -11,176 | -4.4% | 2.91% | $26.6M | $105.38 |
| 2023 Q3 | REDUCED | 252,816 | -2,363 | -0.9% | 2.95% | $24.5M | $92.21 |
As of 2025 Q4 — sorted by position size